FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116713014> ?p ?o ?g. }

• W2116713014 endingPage "16" @default.
• W2116713014 startingPage "1" @default.
• W2116713014 abstract "A three-step model for myofibrillogenesis has been proposed for the formation of myofibrils [Rhee et al., 1994: Cell Motil. Cytoskeleton 28:1–24; Sanger et al., 2002: Adv. Exp. Med. 481:89–105]: premyofibril to nascent myofibril to mature myofibril. We have found two chemically related inhibitors that will arrest development at both the first and second step. Cultured quail embryonic skeletal myoblasts were treated with ethyl methane sulfonate (EMS) or 2-aminoethyl-methanesulfonate (MTSEA+). When the myoblasts fused in the presence of either of these compounds, myosheets rather than myotubes formed. Treated cells were fixed and immunostained against multiple proteins commonly found in muscle cells. Protein expression and localization throughout the myosheet were similar to that of developing myotube tips. Cells treated with high concentrations of EMS (10 mM) stained for non-muscle myosin II, sarcomeric alpha-actinin, and tropomyosin. No zeugmatin (Z-band region of titin) or muscle myosin II antibody staining was detected in fibers in this treatment group. These fibers are comparable to premyofibrils in control myotubes. At lower concentrations of EMS (7.5 to 5 mM), fibers that formed stained for muscle myosin II and titin as well as for non-muscle myosin IIB, sarcomeric alpha-actinin, and tropomyosin. Muscle myosin II was in an unbanded pattern. These fibers are comparable to nascent myofibrils observed during normal myofibrillogenesis. Similar effects to those obtained by treating cells with EMS were obtained when we treated cultured cells with MTSEA+ (5 mM) and stained them with sarcomeric alpha-actinin. MTSEA+ is chemically related to EMS, and is a well-known inhibitor of ryanodine receptors in skeletal muscle cells. Some abnormalities such as nemaline-like rods and other protein aggregates also appear within the myosheet during EMS and MTSEA+ treatment. Removal of these two inhibitors of myofibrillogenesis allows the premyofibrils and nascent myofibrils to form mature myofibrils. Cell Motil. Cytoskeleton 59:1–16, 2004. © 2004 Wiley-Liss, Inc." @default.
• W2116713014 created "2016-06-24" @default.
• W2116713014 creator A5002212432 @default.
• W2116713014 creator A5010160807 @default.
• W2116713014 creator A5029803983 @default.
• W2116713014 date "2004-01-01" @default.
• W2116713014 modified "2023-10-05" @default.
• W2116713014 title "Inhibitors arrest myofibrillogenesis in skeletal muscle cells at early stages of assembly" @default.
• W2116713014 cites W1491346755 @default.
• W2116713014 cites W174516685 @default.
• W2116713014 cites W1971887327 @default.
• W2116713014 cites W1976487383 @default.
• W2116713014 cites W1979310826 @default.
• W2116713014 cites W1994522080 @default.
• W2116713014 cites W2014016916 @default.
• W2116713014 cites W2014548112 @default.
• W2116713014 cites W2028475465 @default.
• W2116713014 cites W2043693509 @default.
• W2116713014 cites W2046771580 @default.
• W2116713014 cites W2058846791 @default.
• W2116713014 cites W2059849324 @default.
• W2116713014 cites W2069373786 @default.
• W2116713014 cites W2093921801 @default.
• W2116713014 cites W2096574019 @default.
• W2116713014 cites W2099209706 @default.
• W2116713014 cites W2101042770 @default.
• W2116713014 cites W2101673030 @default.
• W2116713014 cites W2103597636 @default.
• W2116713014 cites W2105278573 @default.
• W2116713014 cites W2107575131 @default.
• W2116713014 cites W2140452645 @default.
• W2116713014 cites W2153379369 @default.
• W2116713014 cites W6111018 @default.
• W2116713014 doi "https://doi.org/10.1002/cm.20017" @default.
• W2116713014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15259051" @default.
• W2116713014 hasPublicationYear "2004" @default.
• W2116713014 type Work @default.
• W2116713014 sameAs 2116713014 @default.
• W2116713014 citedByCount "22" @default.
• W2116713014 countsByYear W21167130142014 @default.
• W2116713014 countsByYear W21167130142016 @default.
• W2116713014 countsByYear W21167130142019 @default.
• W2116713014 countsByYear W21167130142020 @default.
• W2116713014 crossrefType "journal-article" @default.
• W2116713014 hasAuthorship W2116713014A5002212432 @default.
• W2116713014 hasAuthorship W2116713014A5010160807 @default.
• W2116713014 hasAuthorship W2116713014A5029803983 @default.
• W2116713014 hasConcept C105702510 @default.
• W2116713014 hasConcept C125705527 @default.
• W2116713014 hasConcept C133702464 @default.
• W2116713014 hasConcept C142669718 @default.
• W2116713014 hasConcept C1491633281 @default.
• W2116713014 hasConcept C153911025 @default.
• W2116713014 hasConcept C189040839 @default.
• W2116713014 hasConcept C205875245 @default.
• W2116713014 hasConcept C207200792 @default.
• W2116713014 hasConcept C2779959927 @default.
• W2116713014 hasConcept C2909145422 @default.
• W2116713014 hasConcept C3763915 @default.
• W2116713014 hasConcept C55493867 @default.
• W2116713014 hasConcept C68731436 @default.
• W2116713014 hasConcept C6997183 @default.
• W2116713014 hasConcept C7301908 @default.
• W2116713014 hasConcept C86803240 @default.
• W2116713014 hasConcept C90671521 @default.
• W2116713014 hasConcept C95444343 @default.
• W2116713014 hasConceptScore W2116713014C105702510 @default.
• W2116713014 hasConceptScore W2116713014C125705527 @default.
• W2116713014 hasConceptScore W2116713014C133702464 @default.
• W2116713014 hasConceptScore W2116713014C142669718 @default.
• W2116713014 hasConceptScore W2116713014C1491633281 @default.
• W2116713014 hasConceptScore W2116713014C153911025 @default.
• W2116713014 hasConceptScore W2116713014C189040839 @default.
• W2116713014 hasConceptScore W2116713014C205875245 @default.
• W2116713014 hasConceptScore W2116713014C207200792 @default.
• W2116713014 hasConceptScore W2116713014C2779959927 @default.
• W2116713014 hasConceptScore W2116713014C2909145422 @default.
• W2116713014 hasConceptScore W2116713014C3763915 @default.
• W2116713014 hasConceptScore W2116713014C55493867 @default.
• W2116713014 hasConceptScore W2116713014C68731436 @default.
• W2116713014 hasConceptScore W2116713014C6997183 @default.
• W2116713014 hasConceptScore W2116713014C7301908 @default.
• W2116713014 hasConceptScore W2116713014C86803240 @default.
• W2116713014 hasConceptScore W2116713014C90671521 @default.
• W2116713014 hasConceptScore W2116713014C95444343 @default.
• W2116713014 hasIssue "1" @default.
• W2116713014 hasLocation W21167130141 @default.
• W2116713014 hasLocation W21167130142 @default.
• W2116713014 hasOpenAccess W2116713014 @default.
• W2116713014 hasPrimaryLocation W21167130141 @default.
• W2116713014 hasRelatedWork W1627325189 @default.
• W2116713014 hasRelatedWork W2000415814 @default.
• W2116713014 hasRelatedWork W2058870137 @default.
• W2116713014 hasRelatedWork W2063925852 @default.
• W2116713014 hasRelatedWork W2066425413 @default.
• W2116713014 hasRelatedWork W2086701225 @default.
• W2116713014 hasRelatedWork W2100923800 @default.
• W2116713014 hasRelatedWork W2101042770 @default.

• next